Related Experiment Video

Updated: Jun 6, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic virotherapy for neuroblastoma

Manuel Ramírez1, Javier García-Castro, Ramón Alemany

  • 1Hospital Universitario Niño Jesús, Madrid, Spain. mramirezo.hnjs@salud.madrid.org

Discovery Medicine
|December 3, 2010
PubMed

Insights

Oncolytic virotherapy offers a promising new approach for treating metastatic neuroblastoma (NB), a challenging pediatric cancer. This therapy uses engineered viruses to selectively destroy cancer cells, potentially reducing the toxicity associated with traditional treatments.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Metastatic neuroblastoma (NB) has a poor prognosis, with survival rates below 40% despite intensive treatments.
  • Current therapies like high-dose chemotherapy cause significant toxicity in pediatric patients.
  • Novel therapeutic strategies are urgently needed to improve outcomes for NB.
  • Oncolytic viruses present a promising alternative due to their cancer-selective targeting and potential for reduced toxicity.

Purpose of the Study:

  • To review the preclinical evaluation of oncolytic virotherapy against neuroblastoma.
  • To summarize recent clinical reports on oncolytic virotherapy in refractory pediatric NB cases.
  • To highlight the potential of oncolytic viruses as a novel therapeutic strategy for NB.

Main Methods:

  • Review of preclinical studies investigating oncolytic viruses in NB models.
  • Analysis of genetic modifications in viruses to target cancer-specific pathways.
  • Summary of initial clinical trial data on safety and efficacy in children with refractory NB.

Main Results:

  • Oncolytic viruses demonstrate selective replication and tumor cell killing in preclinical NB models.
  • Engineered viruses can target specific molecular pathways within cancer cells.
  • Early clinical data suggest potential safety and efficacy in children with refractory NB.
  • Viral-mediated cell death may also stimulate anti-tumor immune responses.

Conclusions:

  • Oncolytic virotherapy is a promising emerging treatment for metastatic neuroblastoma.
  • This approach offers a potentially less toxic alternative to conventional chemotherapy.
  • Further clinical investigation is warranted to establish the role of oncolytic viruses in NB treatment.

More Related Videos

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model09:57

Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

Published on: June 4, 2017

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...